Prostate cancer: Treatment triggers for patients on active surveillance

William M. Hilton, Dipen J. Parekh

Research output: Contribution to journalShort survey


Active surveillance (AS) is an option for low-risk prostate cancer. Accurate risk assessment is paramount to select patients for definitive intervention and to avoid overtreatment. Although inaccurate, PSA and Gleason score changes remain common treatment triggers. Biopsy before AS is initiated could avoid misclassification and the need for serial biopsy.

Original languageEnglish (US)
Pages (from-to)126-127
Number of pages2
JournalNature Reviews Urology
Issue number3
StatePublished - Apr 1 2011
Externally publishedYes

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Prostate cancer: Treatment triggers for patients on active surveillance'. Together they form a unique fingerprint.

  • Cite this